BriaCell Therapeutics (BCTX) vs MIRA Pharmaceuticals (MIRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
MIRA Pharmaceuticals (MIRA) has outperformed BriaCell Therapeutics (BCTX) over the past year, losing 44.4% versus a loss of 69.1%. BriaCell Therapeutics is the larger company by market cap ($34.0 million vs $31.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BCTX | MIRA |
|---|---|---|
| Share price | $3.91 | $0.7455 |
| Market cap | $34.02M | $31.33M |
| 1-day change | -0.13% | +6.05% |
| YTD return | -45.01% | -50.63% |
| 1-year return | -69.07% | -44.37% |
| 5-year return | -95.23% | — |
| EPS (TTM) | $-0.92 | $-1.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.68 | $2.45 |
| 52-week low | $2.60 | $0.60 |
| Distance from 52-week high | -73.37% | -69.57% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +369.48% |
| Average volume | 278.91K | 585.75K |
| Shares outstanding | 8.70M | 42.02M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MIRA has outperformed BCTX by 24.7 percentage points over the past year.
About BriaCell Therapeutics
BCTX stock →BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials.
Health Care · Biotechnology: Pharmaceutical Preparations
About MIRA Pharmaceuticals
MIRA stock →MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders.
Health Care · Biotechnology: Pharmaceutical Preparations
BCTX vs MIRA FAQ
Which is bigger, BriaCell Therapeutics or MIRA Pharmaceuticals?
BriaCell Therapeutics (BCTX) is larger, with a market capitalization of $34.02M compared with $31.33M for MIRA Pharmaceuticals (MIRA).
Which stock has performed better over the past year, BCTX or MIRA?
MIRA returned -44.37% over the past 12 months, compared with -69.07% for BCTX (price return, excluding dividends). Past performance does not predict future results.
Are BriaCell Therapeutics and MIRA Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.